ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 7 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $2,000 | -33.3% | 334 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $3,000 | 0.0% | 334 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $3,000 | -25.0% | 334 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $4,000 | -20.0% | 334 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $5,000 | +150.0% | 334 | 0.0% | 0.00% | +100.0% |
| Q3 2013 | $2,000 | -33.3% | 334 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $3,000 | – | 334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 681,500 | $2,481,000 | 1.19% |
| DAFNA Capital Management LLC | 26,000 | $95,000 | 0.04% |
| Rossmore Private Capital | 15,061 | $55,000 | 0.02% |
| Sterling Investment Advisors, Ltd. | 3,150 | $11,000 | 0.01% |
| Close Asset Management Ltd | 7,500 | $27,000 | 0.00% |
| SeaCrest Wealth Management, LLC | 1,500 | $5,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 500 | $2,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,506 | $5,000 | 0.00% |
| MORGAN STANLEY | 26,701 | $97,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 1,600 | $6,000 | 0.00% |